EP 32: Dennis O’Neill — What’s The Difference Between Cannabinoids And Rare Cannabinoids?

Good Dudes Grow

There are cannabinoids, and then there are rare cannabinoids. Found in trace amounts and costly to extract, most of these rare cannabinoids have historically been underutilized, despite their known health benefits. Dennis O’Neill wants to change that.

Dennis came to the cannabis industry from investment banking, where he’d logged over 30 years of his career. While working for banks, including two of Chicago’s most prominent regional investment banks, he had the opportunity to look at “hundreds and hundreds” of cannabis deals, piquing his interest in the growing industry. But it wasn’t until the CEO of BioMediCan, where Dennis is now President, approached him that he understood just how much of an impact he could help make.

“He had a biosynthesis platform where he could produce rare cannabinoids without touching the plant and without producing THC, which makes it outside the federal and state regulations here in the United States, Canada, and Europe,” he says. “I was like, ‘Wow. We’re really onto something here.’”

With four patents pending, BioMediCan’s biosynthesis platform synthesizes rare cannabinoids through a fermentation process akin to brewing beer with four patents pending. The end result? Ninety-nine percent of pharmaceutical-grade cannabinoids are bio-organic, non-GMO, 70-90% less expensive than current market prices, requiring 90% less natural resources and energy.

In this episode of Good Dudes Grow, Gary and Dennis talk about the future of rare cannabinoids and what they offer that the more common cannabinoids, including THC and CBD, don’t.

What You'll Learn:

• Why Dennis views his company’s biosynthesis platform as a “sustainability project”
• What the benefits of rare cannabinoids are including CBG, which has been shown to help with everything from glaucoma to IBS to Huntington's Disease
• What the existing 22 clinical trials on CBD, as well as the 40 that are currently underway, can tell us about the effectiveness of cannabinoids
• And much more!

Favorite Quote:

“It's not easy growing cannabis or hemp; it's a tough business. It’s a back-breaking business. This is a way for everybody to benefit because we're all trying to change the world by getting people more healthy through the benefits of cannabinoids. And the higher quality and the lower cost that we can provide, the more people that we can help.”

— Dennis O’Neill

Connect with Dennis:

LinkedIn

Facebook

How to get involved:

Gary Roberts is the founder and CEO of Pure Body Zen, a company based not only around creating and selling high-quality CBD products, but one that is on a mission to change the landscape on how mental health and addiction are treated. Gary has founded a non-profit called Promises Recovery Centers for those who need it as well as creating the first-ever educational training facility for Physicians, Therapists, and Mental Health advocates using innovative therapeutics like psilocybin, Mdma, and LSD.

You can learn more about Pure Body Zen on their site, on LinkedIn, and on Instagram.

If you enjoyed this episode, don’t forget to visit the show on Apple Podcasts and leave a rating and review! We love hearing from you!

--

We bring unbiased content educating you about Hemp CBD, Cannabis, and Innovative Therapeutics like Psychedelics.

Helping people understand the benefits of Hemp CBD, Cannabis, and Psychedelics, removing the fear of the unknown, and dispelling myths, and presenting facts.

Are you unsure about Hemp-Derived CBD, Cannabis, and Psychedelics but are interested in learning more about the benefits of this alternative solution to big pharma?

We will step out into the unknown to have a clear understanding of what is and isn’t possible with Plant-Base Medicine and breakthrough therapies using Psychedelics through success stories about health, business, and more.